AAAAAA
Results:
1-15
|
Results: 15
Authors:
Tuveson, DA
Willis, NA
Jacks, T
Griffin, JD
Singer, S
Fletcher, CDM
Fletcher, JA
Demetri, GD
Citation: Da. Tuveson et al., STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications, ONCOGENE, 20(36), 2001, pp. 5054-5058
Authors:
Cibas, ES
Goss, GA
Kulke, MH
Demetri, GD
Fletcher, CDM
Citation: Es. Cibas et al., Malignant epithelioid angiomyolipoma ('Sarcoma ex angiomyolipoma') of the kidney - A case report and review of the literature, AM J SURG P, 25(1), 2001, pp. 121-126
Authors:
Joensuu, H
Roberts, PJ
Sarlomo-Rikala, M
Andersson, LC
Tervahartiala, P
Tuveson, D
Silberman, SL
Capdeville, R
Dimitrijevic, S
Druker, B
Demetri, GD
Citation: H. Joensuu et al., Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor., N ENG J MED, 344(14), 2001, pp. 1052-1056
Authors:
Rubin, BP
Singer, S
Tsao, C
Duensing, A
Lux, ML
Ruiz, R
Hibbard, MK
Chen, CJ
Xiao, S
Tuveson, DA
Demetri, GD
Fletcher, CDM
Fletcher, JA
Citation: Bp. Rubin et al., KIT activation is a ubiquitous feature of gastrointestinal stromal tumors, CANCER RES, 61(22), 2001, pp. 8118-8121
Authors:
Demetri, GD
Citation: Gd. Demetri, Anaemia and its functional consequences in cancer patients: current challenges in management and prospects for improving therapy, BR J CANC, 84, 2001, pp. 31-37
Authors:
Esnaola, NF
Rubin, BP
Baldini, EH
Vasudevan, N
Demetri, GD
Fletcher, CDM
Singer, S
Citation: Nf. Esnaola et al., Response to chemotherapy and predictors of survival in adult rhabdomyosarcoma, ANN SURG, 234(2), 2001, pp. 215-223
Authors:
Ozer, H
Armitage, JO
Bennett, CL
Crawford, J
Demetri, GD
Pizzo, PA
Schiffer, CA
Smith, TJ
Somlo, G
Wade, JC
Wade, JL
Winn, RJ
Wozniak, AJ
Somerfield, MR
Citation: H. Ozer et al., 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: Evidence-based, clinical practice guidelines, J CL ONCOL, 18(20), 2000, pp. 3558-3585
Authors:
Blobe, GC
Mantel, M
Janicek, M
Demetri, GD
Citation: Gc. Blobe et al., Two patients with sarcoma - Case 2. Uterine sarcoma, J CL ONCOL, 18(11), 2000, pp. 2343-2344
Authors:
Demetri, GD
Citation: Gd. Demetri, Pharmacologic treatment options in patients with thrombocytopenia, SEM HEMATOL, 37(2), 2000, pp. 11-18
Authors:
Demetri, GD
Citation: Gd. Demetri, Role of iron in optimizing responses of anemic cancer patients to erythropoietin - The Glaspy/Cavill article reviewed, ONCOLOGY-NY, 13(4), 1999, pp. 484
Authors:
Baldini, EH
Goldberg, J
Jenner, C
Manola, JB
Demetri, GD
Fletcher, CDM
Singer, S
Citation: Eh. Baldini et al., Long-term outcomes after function-sparing surgery without radiotherapy forsoft tissue sarcoma of the extremities and trunk, J CL ONCOL, 17(10), 1999, pp. 3252-3259
Authors:
Demetri, GD
Fletcher, CDM
Mueller, E
Sarraf, P
Naujoks, R
Campbell, N
Spiegelman, BM
Singer, S
Citation: Gd. Demetri et al., Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma, P NAS US, 96(7), 1999, pp. 3951-3956
Uptake of radiolabeled somatostatin analog is detectable in patients with metastatic foci of sarcoma
Authors:
Friedberg, JW
Van den Abbeele, AD
Kehoe, K
Singer, S
Fletcher, CD
Demetri, GD
Citation: Jw. Friedberg et al., Uptake of radiolabeled somatostatin analog is detectable in patients with metastatic foci of sarcoma, CANCER, 86(8), 1999, pp. 1621-1627
Authors:
Baldini, EH
Demetri, GD
Fletcher, CDM
Foran, J
Marcus, KC
Singer, S
Citation: Eh. Baldini et al., Adults with Ewing's sarcoma primitive neuroectodermal tumor - Adverse effect of older age and primary extraosseous disease on outcome, ANN SURG, 230(1), 1999, pp. 79-86
Authors:
Demetri, GD
Citation: Gd. Demetri, Evidence-based use of hematopoietic cytokines in clinical oncology, CLINICAL APPLICATIONS OF CYTOKINES AND GROWTH FACTORS, 1999, pp. 137-149
Risultati:
1-15
|